|

Sacituzumab Govitecan-Hziy 180 MG plus bevacizumab Clinical Trials

1 actively recruiting trial

Also known as: sacituzumab govitecan; zirabev

Pipeline

Phase 2: 1

Top Sponsors

  • Maastricht University Medical Center1

Indications

  • NSCLC Stage IV1
  • Brain Metastases, Adult1
  • Lung Cancer1
  • Cancer1

Other1 trial

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.